ADC Therapeutics is a biopharmaceuticals company developing a pipeline of anti-cancer products based on antibody drug conjugation technology developed by Spirogen Limited.
Bango is a mobile payments and analytics service provider. Bango floated on AIM on 30 June 2005 – EPIC code BGO.
Cambridge Display Technology develops and supplies proprietary materials for OLED displays based on technology developed at the Cavendish Laboratory. CDT floated on NASDAQ in December 2004 and has since been acquired by Sumitomo Chemcial Co Ltd.
Equitalk is a low cost web-based telephony provider. Equitalk was acquired by Xfone Inc in July 2006.
Oxsight, a spin-out from Oxford University, enables people with low vision to gain greater independence and quality of life through intelligent smart glasses.
Phico is a therapeutic biotechnology company developing treatments for multiply resistant bacteria.
Plastic Logic develops and manufactures printable, flexible plastic semiconductors, exploiting technology developed at the Cavdendish Laboratory in the University of Cambridge.
Signify is an authentication and identity management service provider. Signify was acquired by Accumuli plc (now part of NCC plc) in June 2013.
Silicon Fuel has developed a unique nanomaterial which generates hydrogen via reaction with water, enabling safe and efficient hydrogen storage for power generation through fuel cells.
Solcom develops systems for controlling advanced medical processes, particularly nuclear medicine. QTP, a fund managed by ETCapital, sold its interest in Solcom in October 2008.
Spirogen develops complex molecules and a platform technology for antibody drug conjugation being utilised in innovative anti cancer therapies. Spirogen was acquired by AstraZeneca in November 2013.